COVID-19, Flu & RSV
COVID-19 Rapid Ag Self-Test Kit (FDA Approved)
$7.99 – $11.99
Rapid Self-Test Kit for SARS-CoV-2 Antigens is an accurate and easy-to-use solution for detecting COVID-19 manufactured by Genabio.
This non-prescription test is designed for self-testing at home with anterior nasal swab specimens. It is authorized for individuals aged 14 years or older, or adult-collected samples from individuals aged 2 years or older within the first 7 days of symptom onset. With improved performance in detecting Omicron variants, this Rapid Self-Test Kit provides reliable results that US FDA authority has approved for EUA.
Each test includes a short nasal swab, buffer tube with drop cap, foil-sealed test cassette, and clear instructions. Results are available within 15 minutes. This test comes in sizes of 1 test/pack and 2 tests/pack, and the compact packaging reduces costs and is more environmentally friendly. Manufactured in ISO13485 accredited Genabio facilities.
Select options
This product has multiple variants. The options may be chosen on the product page
Flu A/B & COVID-19 Multiplex Rapid Test (3-in-1 Home Self-Test)
$14.99 – $21.99
This test is authorized for the qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B protein antigens. This test is authorized for non-prescription home use with self-collected anterior nasal swab specimens from individuals aged 14 years or older, or with adult-collected anterior nasal swab specimens from individuals two (2) years or older.
Stay ahead of the curve and ensure your health with our latest Tyfast Flu A/B & COVID-19 Multiplex Rapid Home Test Kit (OTC options). This state-of-the-art rapid test empowers you to quickly check for both flu (A & B) and COVID-19 infection from the comfort of your home in just 10 minutes. Perfect for anyone experiencing symptoms of respiratory diseases, our kit offers peace of mind with swift and accurate results.
- Enjoy Fast Results: Get clear answers fast, enabling you to take the next steps sooner.
- Multi Target: Taking control of your health has never been easier or more convenient. Get fast, accurate, and reliable results, and stay one step ahead of flu and COVID-19.
- Rely on Precision: Trust in the clinical accuracy that accurately detects flu and COVID-19 antigens, giving you the certainty you need.
- User-Friendly: Our simple, straightforward design makes at-home testing a breeze, no matter where you are.
- Nasal Swab
Select options
This product has multiple variants. The options may be chosen on the product page
SARS-CoV-2/Flu A/FLu B/RSV/ADV/MP Antigen Rapid Test Kits
$29.991 Test/BoxIntended Use
The visual reading test kit is a rapid, qualitative diagnostic tool designed for the simultaneous detection of antigens from six major respiratory pathogens: SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus, and Mycoplasma pneumoniae. This test is intended for use with throat swab specimens collected from individuals exhibiting symptoms of respiratory tract infections, such as cough, fever, sore throat, or difficulty breathing.
The primary purpose of this six-in-one respiratory panel is to provide accurate and timely identification of the causative pathogen responsible for respiratory illnesses. By detecting specific antigens associated with these pathogens, the kit aids in differentiating between viral and bacterial infections, enabling healthcare providers to make informed decisions regarding treatment and infection control measures.
This test is particularly valuable in clinical settings, such as hospitals, outpatient clinics, and emergency departments, where rapid diagnosis is critical for patient management and preventing the spread of infectious diseases. It is also suitable for use in point-of-care (POC) settings, such as your doctor office or at-home testing, offering results within 15–20 minutes without the need for specialized laboratory equipment.
Timely and accurate diagnostic testing not only improves patient outcomes but also informs public health initiatives and targeted interventions. This necessity becomes more apparent during outbreaks or pandemics, like COVID-19 and other air-borne viruses or bacteria when rapid testing is essential for identifying cases, implementing containment measures, and allocating resources. Diagnostic testing provides reliable data for evidence-based decision-making, crucial for mitigating the impact of infectious diseases on individuals and communities.